Noumed Pharmaceuticals

Noumed Pharmaceuticals, part of UK company Noumed Life Sciences, will build an $85 million drug manufacturing facility at Salisbury South in northern Adelaide, with a $20 million grant from the federal government's Modern Manufacturing Initiative. The facility will create 180 ongoing jobs and produce around 40 million units of tablets, creams, and liquids when it opens in 2025.